Abbott Laboratories total revenue, net income and dynamics of changes in Euro today
The dynamics of Abbott Laboratories net revenue has changed by -233 000 000 € over the last period. The dynamics of Abbott Laboratories net income went down. The change was -604 000 000 €. Net income, revenue and dynamics - the main financial indicators of Abbott Laboratories. Abbott Laboratories financial report on a graph in real time displays the dynamics, i.e. change in fixed assets of the company. The value of "net income" Abbott Laboratories on the graph is displayed in blue. The value of the "total revenue of Abbott Laboratories" on the chart is marked in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021
9 538 273 683 €
+28.12 % ↑
1 109 361 969 €
+18.19 % ↑
31/03/2021
9 755 667 576 €
+38.77 % ↑
1 672 906 653 €
+166.82 % ↑
31/12/2020
9 984 257 721 €
+28.71 % ↑
2 017 191 402 €
+106.1 % ↑
30/09/2020
8 260 034 913 €
+9.62 % ↑
1 149 481 872 €
+28.33 % ↑
31/12/2019
7 757 136 594 €
-
978 739 029 €
-
30/09/2019
7 535 077 596 €
-
895 700 160 €
-
30/06/2019
7 444 574 559 €
-
938 619 126 €
-
31/03/2019
7 030 313 235 €
-
626 990 112 €
-
Show:
to
Abbott Laboratories financial report charts
Dates of Abbott Laboratories finance reports: 31/03/2019, 31/03/2021, 30/06/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The current date of the financial report of Abbott Laboratories for today is 30/06/2021. Gross profit Abbott Laboratories is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Abbott Laboratories is 5 807 000 000 €
Abbott Laboratories quarterly report dates
Cost of revenue Abbott Laboratories is the total cost of producing and distributing of products and services of a company. Cost of revenue Abbott Laboratories is 4 416 000 000 € Total revenue Abbott Laboratories refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Abbott Laboratories is 10 223 000 000 € Operating income Abbott Laboratories is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Abbott Laboratories is 1 941 000 000 €
Net income Abbott Laboratories is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Abbott Laboratories is 1 189 000 000 €
30/06/2021
31/03/2021
31/12/2020
30/09/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
5 418 052 947 €
5 650 375 176 €
5 791 261 347 €
4 559 673 627 €
4 559 673 627 €
4 401 993 078 €
4 385 198 700 €
4 096 895 211 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
4 120 220 736 €
4 105 292 400 €
4 192 996 374 €
3 700 361 286 €
3 197 462 967 €
3 133 084 518 €
3 059 375 859 €
2 933 418 024 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
9 538 273 683 €
9 755 667 576 €
9 984 257 721 €
8 260 034 913 €
7 757 136 594 €
7 535 077 596 €
7 444 574 559 €
7 030 313 235 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 810 993 761 €
2 031 186 717 €
2 361 476 151 €
1 350 081 387 €
1 383 670 143 €
1 169 075 313 €
1 177 472 502 €
776 273 472 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
1 109 361 969 €
1 672 906 653 €
2 017 191 402 €
1 149 481 872 €
978 739 029 €
895 700 160 €
938 619 126 €
626 990 112 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
608 329 692 €
610 195 734 €
599 932 503 €
541 152 180 €
536 487 075 €
556 080 516 €
538 353 117 €
625 124 070 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
7 727 279 922 €
7 724 480 859 €
7 622 781 570 €
6 909 953 526 €
6 373 466 451 €
6 366 002 283 €
6 267 102 057 €
6 254 039 763 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
-
20 355 719 157 €
19 071 882 261 €
16 225 235 190 €
14 617 640 007 €
15 039 365 499 €
14 177 254 095 €
13 443 899 589 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
-
67 909 933 485 €
67 688 807 508 €
64 418 568 903 €
63 339 996 627 €
63 948 326 319 €
63 843 827 967 €
63 081 549 810 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
-
7 514 551 134 €
6 379 997 598 €
4 179 934 080 €
3 601 461 060 €
3 816 988 911 €
2 926 886 877 €
2 819 589 462 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
10 135 407 123 €
9 788 323 311 €
8 455 036 302 €
8 502 620 373 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
34 135 506 306 €
34 073 926 920 €
34 086 056 193 €
34 037 539 101 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
53.89 %
53.28 %
53.39 %
53.96 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
31 314 050 802 €
31 314 050 802 €
30 588 160 464 €
29 283 797 106 €
29 005 756 848 €
29 685 929 157 €
29 563 703 406 €
28 853 674 425 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
2 254 178 736 €
1 817 524 908 €
989 002 260 €
664 310 952 €
Last revenue report of Abbott Laboratories was 30/06/2021. According to last financial report total revenue in Abbott Laboratories was 9 538 273 683 Euro and changed by +28.12% since last year. Net income in Abbott Laboratories was 1 109 361 969 € in last quartal, net income changes to +18.19%.
